These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 27924267

  • 1. Effects of substrate conformational strain on binding kinetics of catalytic antibodies.
    Oda M, Tsumuraya T, Fujii I.
    Biophys Physicobiol; 2016; 13():135-138. PubMed ID: 27924267
    [Abstract] [Full Text] [Related]

  • 2. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
    Oda M, Ito N, Tsumuraya T, Suzuki K, Sakakura M, Fujii I.
    J Mol Biol; 2007 May 25; 369(1):198-209. PubMed ID: 17428500
    [Abstract] [Full Text] [Related]

  • 3. Structural basis of the transition-state stabilization in antibody-catalyzed hydrolysis.
    Sakakura M, Takahashi H, Shimba N, Fujii I, Shimada I.
    J Mol Biol; 2007 Mar 16; 367(1):133-47. PubMed ID: 17239396
    [Abstract] [Full Text] [Related]

  • 4. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution.
    Kristensen O, Vassylyev DG, Tanaka F, Morikawa K, Fujii I.
    J Mol Biol; 1998 Aug 21; 281(3):501-11. PubMed ID: 9698565
    [Abstract] [Full Text] [Related]

  • 5. Site-directed mutagenesis of active site contact residues in a hydrolytic abzyme: evidence for an essential histidine involved in transition state stabilization.
    Miyashita H, Hara T, Tanimura R, Fukuyama S, Cagnon C, Kohara A, Fujii I.
    J Mol Biol; 1997 Apr 18; 267(5):1247-57. PubMed ID: 9150409
    [Abstract] [Full Text] [Related]

  • 6. Diverse structural solutions to catalysis in a family of antibodies.
    Gigant B, Tsumuraya T, Fujii I, Knossow M.
    Structure; 1999 Nov 15; 7(11):1385-93. PubMed ID: 10574796
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Catalytic antibodies: generation of a new class of protein catalysts exploiting the immune system].
    Fujii I.
    Yakugaku Zasshi; 1996 Aug 15; 116(8):606-21. PubMed ID: 8831262
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro abzyme evolution to optimize antibody recognition for catalysis.
    Takahashi N, Kakinuma H, Liu L, Nishi Y, Fujii I.
    Nat Biotechnol; 2001 Jun 15; 19(6):563-7. PubMed ID: 11385462
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.